Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group
Top Cited Papers
Open Access
- 20 January 2022
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 76 (4) , 841-849
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Diagnosis and Management of Autoimmune HepatitisHepatology, 2010
- Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: A randomized placebo-controlled treatment trialHepatology, 1999
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Oral pulse prednisone therapy after relapse of severe autoimmune chronic active hepatitisJournal of Hepatology, 1993
- Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawalHepatology, 1988
- RANDOMISED CONTROLLED TRIAL OF AZATHIOPRINE WITHDRAWAL IN AUTOIMMUNE CHRONIC ACTIVE HEPATITISThe Lancet, 1985
- Controlled trial of a thymic hormone extract (Thymostimulin) in 'autoimmune' chronic active hepatitis.Gut, 1984
- Azathioprine versus prednisone in non‐alcoholic chronic liver disease (CLD). Relation to a serological classificationLiver International, 1982
- Controlled trial of synthetic D-penicillamine and prednisone in maintenance therapy for active chronic hepatitis.Gut, 1977
- CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITISThe Lancet, 1973